![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, December 18, 2014 4:03:41 PM
AEMD $$$$ Zacks Upgrades AEMD to Buy!:))) http://finance.yahoo.com/news/zacks-upgrades-aemd-buy-130000386.html
AEMD daily
http://stockcharts.com/h-sc/ui?s=AEMD&p=D&yr=0&mn=3&dy=0&id=p10643403717
AEMD weekly
http://stockcharts.com/h-sc/ui?s=AEMD&p=W&yr=0&mn=3&dy=0&id=p04538205952
SeeThruEquity Issues Company Note on Aethlon Medical's First Treatment of Ebola Patient and Raises Target Price to $0.74
http://finance.yahoo.com/news/seethruequity-issues-company-note-aethlon-140000144.html
Aethlon Medical Initiates Patient Recruitment for FDA Approved Clinical Study
http://finance.yahoo.com/news/aethlon-medical-initiates-patient-recruitment-121500273.html
Aethlon Medical: One Device – One Country – $1 Billion
http://edvadaily.com/aethlon-medical-one-device-one-country-1-billion/
Aethlon Medical® Reports Rapid and Sustained Virologic Response Rates in Hepatitis C (HCV) Treated Patients
http://ih.advfn.com/p.php?pid=nmona&article=64635932
Aethlon Medical Announces $3.3 Million Equity Investment
http://ih.advfn.com/p.php?pid=nmona&article=64577821
http://ih.advfn.com/p.php?pid=nmona&article=64597064
Aethlon Medical Announces First Hemopurifier® Shipment To Support the Treatment of Ebola in the United States
http://ih.advfn.com/p.php?pid=nmona&article=64570460
Ebola Patient Who Received Aethlon Hemopurifier® Therapy Has Been Discharged From Hospital
http://ih.advfn.com/p.php?pid=nmona&article=64552425
Time Magazine Names The Aethlon Hemopurifier® One of the 25 Best Inventions of 2014
http://ih.advfn.com/p.php?pid=nmona&article=64519589
Aethlon Medical Discloses Expanded Access "Emergency Use" Pathway To Treat Ebola in the United States
http://ih.advfn.com/p.php?pid=nmona&article=64485962
Aethlon Medical's Hemopurifier® Used in Successful Treatment of Patient with Advanced Ebola Infection
http://ih.advfn.com/p.php?pid=nmona&article=64423283
http://www.kusi.com/video?clipId=10695161&autostart=true
Recent AEMD News
- Aethlon Medical Receives Ethics Committee Approval for Hemopurifier® Cancer Trial • PR Newswire (US) • 06/18/2024 12:01:00 PM
- Aethlon Medical Prepares for Potentially Transformative Phase 1 Cancer Treatment Studies • PR Newswire (US) • 06/03/2024 12:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/24/2024 05:24:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/17/2024 08:05:28 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 05/17/2024 04:15:21 AM
- Form 424B4 - Prospectus [Rule 424(b)(4)] • Edgar (US Regulatory) • 05/16/2024 08:05:23 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 05/15/2024 01:27:15 PM
- Aethlon Medical Announces Pricing of $4.7 Million Public Offering • PR Newswire (US) • 05/15/2024 01:15:00 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 05/13/2024 09:30:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/10/2024 12:01:40 PM
- Aethlon Medical Reports Positive Results From an In Vitro Binding Study of Its Hemopurifier® in Removing Extracellular Vesicles From Cancer Patient Plasma • PR Newswire (US) • 05/10/2024 12:01:00 PM
- Aethlon Medical Enters Into Materials Transfer Agreement for Santersus AG's NucleoCapture and HemoNucleoCapture Devices • PR Newswire (US) • 02/21/2024 01:01:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 10:15:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/14/2024 09:15:41 PM
- Aethlon Medical Announces Fiscal Third Quarter Financial Results and Provides Corporate Update • PR Newswire (US) • 02/14/2024 09:15:00 PM
- Aethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 14, 2024 • PR Newswire (US) • 02/07/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2024 11:06:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2024 11:04:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2024 11:02:52 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 12/22/2023 09:01:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/27/2023 12:49:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2023 09:15:39 PM
- Aethlon Medical Announces Fiscal Second Quarter Financial Results and Provides Corporate Update • PR Newswire (US) • 11/14/2023 09:15:00 PM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM